Skip Content
You are currently on the new version of our website. Access the old version .
  • 1.8
    Impact Factor
  • 23 days
    Time to First Decision

Pharmacy, Volume 14, Issue 1

2026 February - 23 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (23)

  • Article
  • Open Access
268 Views
10 Pages

Comparison of Subcutaneous Versus Intramuscular Estradiol Administration for Feminizing Gender-Affirming Hormone Therapy

  • Abby C. Poage,
  • Jordan M. Rowe,
  • Mary Beth A. Dameron,
  • Abigail M. Bavuso and
  • Andrew J. Smith

23 January 2026

This single health system, retrospective cohort study compared subcutaneous (SC) versus intramuscular (IM) estradiol administration in 70 adult patients with a diagnosis of gender incongruence or gender dysphoria seen in an LGBTQ Specialty Clinic wit...

  • Article
  • Open Access
186 Views
15 Pages

Drug-Drug Interaction Knowledge, Practices, and Barriers in Community Pharmacies: A Cross-Sectional Study from Jazan Region, Saudi Arabia

  • Moaddey Alfarhan,
  • Muath F. Haqwi,
  • Abdulrahman H. Musayyikh,
  • Jala Ashqar,
  • Lama Y. Suwidi,
  • Amal H. Fageh,
  • Enas A. Alajam,
  • Hadi Almansour,
  • Thamir M. Alshammari and
  • Saeed Al-Qahtani

23 January 2026

(1) Background: Drug–drug interactions (DDIs) are a frequent cause of medication-related harm, particularly in ambulatory care. Community pharmacists are uniquely positioned to identify and manage these risks. This study assessed DDI knowledge,...

  • Article
  • Open Access
114 Views
10 Pages

22 January 2026

Evidence linking medication regimen complexity to patient-reported adverse drug events (ADEs) is limited. This study examined the association between regimen complexity and patient-reported ADEs among adults using community pharmacy services. A cross...

  • Article
  • Open Access
181 Views
12 Pages

16 January 2026

Foundational biomedical sciences are commonly taught without routine integration of local population health contexts, limiting students’ ability to connect mechanisms to community disease burden and practice responsibilities. In this method pap...

  • Review
  • Open Access
243 Views
11 Pages

Irisin as a Neuroprotective Agent in Parkinson’s Disease: The Role of Physical Exercise in Modulating Dopaminergic Neurons

  • José Garcia de Brito-Neto,
  • Paulo Leonardo de Góis Morais,
  • José Rodolfo Lopes de Paiva Cavalcanti,
  • Francisco Irochima Pinheiro,
  • Fausto Pierdoná Guzen and
  • Ricardo Ney Cobucci

13 January 2026

Exercise-induced myokines have emerged as crucial mediators of the beneficial effects of physical activity on neurodegenerative diseases through complex molecular mechanisms involving oxidative stress reduction, neuroinflammation suppression, and syn...

  • Article
  • Open Access
182 Views
15 Pages

Patient and Physician Perspectives on Pharmacotherapy in Parkinson’s Disease Psychosis: A Mixed-Methods Exploratory Study

  • Olaf Rose,
  • Tobias Hinteregger,
  • Eugen Trinka,
  • Bernhard Iglseder,
  • Johanna Pachmayr and
  • Stephanie Clemens

13 January 2026

Psychosis is a frequent and disabling non-motor complication of Parkinson’s disease (PD). Clozapine and quetiapine are widely used in the treatment of Parkinson’s disease psychosis (PDP). We conducted an exploratory study to compare patie...

  • Article
  • Open Access
267 Views
19 Pages

Leveraging Artificial Intelligence-Based Applications to Remove Disruptive Factors from Pharmaceutical Care: A Quantitative Study in Eastern Romania

  • Ionela Daniela Ferțu,
  • Alina Mihaela Elisei,
  • Mariana Lupoae,
  • Alexandra Burlacu,
  • Claudia Simona Ștefan,
  • Luminița Enache,
  • Andrei Vlad Brădeanu,
  • Loredana Sabina Pascu,
  • Iulia Chiscop and
  • Ancuța Iacob
  • + 2 authors

9 January 2026

Artificial Intelligence (AI) has increasingly contributed to advancements in pharmaceutical practice, particularly by enhancing the pharmacist–patient relationship and improving medication adherence. This quantitative, descriptive, cross-sectio...

  • Article
  • Open Access
527 Views
11 Pages

Epidemiological Assessment of Benzodiazepine Dependence via Pharmacist-Led EMR Review in Pain and Palliative Care Institution

  • Carlos Eduardo Estrada-De La Rosa,
  • Felipe Alexis Avalos-Salgado,
  • Daniel Osmar Suárez-Rico,
  • Martin Zermeño-Ruiz,
  • César Ricardo Cortez-Álvarez and
  • Raymundo Escutia-Gutiérrez

7 January 2026

Background/Objectives: Benzodiazepines (BZDs) are used routinely in cases requiring sedation for anxiety, insomnia, and procedures that require pain management, and daily use of these agents may extend over several months; therefore, monitoring patie...

  • Article
  • Open Access
337 Views
17 Pages

6 January 2026

People with intellectual disabilities frequently use psychotropic and other medications, sometimes inappropriately. To promote shared decision-making, they require accessible information about their medication. This study combined data from two simil...

  • Article
  • Open Access
308 Views
14 Pages

Beyond Addiction: Burden of Polypharmacy and Risk in Frail Patients with Substance Use Disorder

  • L. Goretti Santiago Gutiérrez,
  • Daida Alberto Armas,
  • Verónica Hernández García,
  • Juan Ramón Santana Ayala,
  • Roberto García Sánchez,
  • Soraya Paz Montelongo,
  • Ángel J. Gutiérrez,
  • Arturo Hardisson de la Torre and
  • Carmen Rubio Armendáriz

1 January 2026

Substance use disorder (SUD) is a chronic and clinically complex condition, frequently complicated by significant organic and psychiatric comorbidities. Most patients are polymedicated and require opioid substitution programs (OSPs). This complexity...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmacy - ISSN 2226-4787